Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

FENTANYL

FENTANYL CITRATE

Standard Dose
EQ 0.3MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview FENTANYL is listed in Drugs@FDA under application 020195 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;ORAL - EQ 0.3MG BASE Sponsor CEPHALON Submission history Latest submission status date: 2000-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENTANYL is listed in Drugs@FDA under application 020195 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;ORAL - EQ 0.3MG BASE Sponsor CEPHALON Submission history Latest submission status date: 2000-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.